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ABSTRACT
Patients suffering from glycogen storage disease V (McArdle
disease) were shown to have higher surface electrical activity in
their skeletal muscles when exercising at the same intensity as their
healthy counterparts, indicating more muscle fibre recruitment. To
explain this phenomenon, this study investigated whether muscle
fibre type is shifted towards a predominance in type I fibres as a
consequence of the disease. Muscle biopsies from the Biceps
brachii (BB) (n59) or Vastus lateralis (VL) (n58) were collected
over a 13-year period from male and female patients diagnosed with
McArdle disease, analysed for myosin heavy chain (MHC) isoform
content using SDS-PAGE, and compared to healthy controls (BB:
n53; VL: n510). All three isoforms were expressed and no
difference in isoform expression in VL was found between the
McArdle patients and healthy controls (MHC I: 33619% vs. 4367%;
MHC IIa: 5269% vs. 4067%; MHC IIx: 15618% vs. 1769%).
Similarly, the BB isoform content was also not different between the
two groups (MHC I: 33614% vs. 30611%; MHC IIa: 46617% vs.
3965%; MHC IIx: 21613% vs. 31614%). In conclusion, fibre type
distribution does not seem to explain the higher surface EMG in
McArdle patients. Future studies need to investigate muscle fibre
size and contractility of McArdle patients.
KEY WORDS: Myosin heavy chain, Glycogen storage disease V,
Phosphorylase deficiency
INTRODUCTION
McArdle patients suffer from glycogen storage disease V and
have limited endogenous glycogen for use during exercise. They
find exercise difficult and fatigue quickly, presumably since they
initially rely on blood glucose from exogenous sources for fuel.
They often, however, report a ‘‘second-wind’’ effect, coinciding
with the mobilisation of free-fatty acids for fuel (Lucia et al.,
2008; van Adel and Tarnopolsky, 2009). As a result, many
McArdle patients avoid exercise, or are advised that exercise is
contra-indicated for their condition, which may inadvertently
decrease their quality of life. A recent study found that patients
suffering from McArdle disease produced less force, fatigued
faster, and surprisingly recorded almost three times as much
surface electrical activity in their skeletal muscles (measured by
electromyography) compared to healthy controls exercising at the
same intensity (Rae et al., 2010). Surface EMG activity correlates
well with the number of active motor units (Moritani and Muro,
1987), and are therefore good proxies for muscle fibre
recruitment. Although some evidence exist that muscle fibre
type correlates with EMG activity in vitro, it is still unclear
whether this holds true in vivo (Farina, 2008; Kupa et al., 1995;
von Tscharner and Nigg, 2008). In theory, this should hold true,
but current techniques in pinpointing EMG activities to a
particular fibre or fibre type is still in its infancy. Nevertheless,
Rae et al. (Rae et al., 2010) suggested that this excessive muscle
recruitment might be attributed to altered contractile properties of
the diseased muscle, perhaps compounding the exercise
intolerance experienced by McArdle patients.
Muscle fibre type plays an important role in determining the
amount of force and power output a muscle can produce, as well as
its resistance to fatigue. It is well documented that type I fibres
produce less force and power, have slower contraction speeds, but
are more resistant to fatigue than type IIA muscle fibres (Esse´n-
Gustavsson and Henriksson, 1984; Kohn and Noakes, 2013). The
fatigue resistance is primarily attributed to abundant mitochondria
found in type I fibres and its ability to utilise fat as a fuel source to
generate ATP for muscle contraction (Bottinelli, 2001; Pette, 1985).
Type IIA fibres produce force and power levels below that of type
IIX fibres, but significantly higher than type I fibres, have high
mitochondrial content, rely on glycogen and fat stores for ATP
replenishment, and withstand fatigue for longer periods of time than
type IIX fibres (Pette, 1985). It is well known that endurance
athletes have predominantly type I and IIA fibres in their Vastus
lateralis (VL) muscle, with high mitochondrial numbers (Esse´n-
Gustavsson and Henriksson, 1984; Kohn et al., 2007b). Sedentary
individuals and sprinters have a greater proportion of type IIX
muscle fibres, but rarely more than their type I or type IIA fibres
(Andersen et al., 1994; Kohn et al., 2007a). Diseases, such as
Duchene’s muscular dystrophy, was shown to shift the fibre type
profile to type I and IIA, even when they also struggle to perform
exercise (Fink et al., 1990). To date, very little data exist
surrounding muscle fibre type of McArdle patients, specifically
whether this disease affects overall fibre type composition.
This study therefore aimed to determine muscle fibre type
composition in biopsies from the Biceps brachii (BB) or the VL
from McArdle patients, and compare it to healthy controls. The
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hypothesis was that McArdle patients would have a
predominance of type I muscle fibres and significantly more
than their healthy counterparts, resulting from an adaptation to
rely primarily on fat as a fuel source, due to their inability to
utilise their glycogen stores.
RESULTS AND DISCUSSION
To our knowledge, this is the first study reporting the muscle fibre
type composition in patients with McArdle disease. The main
finding is that McArdle patients had similar fibre type profiles as
controls.
Three MHC isoforms (I, IIa and IIx) were found in the
McArdle and control samples. The MHC isoforms were separated
and identified in healthy control samples using the SDS-PAGE
technique and corresponded to (top to bottom) MHC IIx, MHC
IIa and MHC I (Fig. 1). This method is well characterised and
provides good estimates of relative muscle fibre type from
biopsies (Andersen et al., 1994; Curry et al., 2012; Kohn et al.,
2007b). No additional bands were detected in control and
McArdle samples that may indicate the expression of the IIb,
neonatal or embryonic isoforms, as is found in low quantities in
regenerating fibres due to exercise or disease (Bottinelli, 2001;
D’Antona et al., 2003; Fink et al., 1990; Schiaffino and Reggiani,
1996; Williams et al., 1993).
As McArdle disease is rare [,1 in 170 000 people in Spain
(Lucia et al., 2012)], the patient’s data and biopsies were
collected over a 13-year period, from both males and females,
with a wide age range (17 to 76 years) and biopsies were taken
non-intentionally from two muscle groups (VL and BB). Given
that the data had to be grouped by muscle for analysis, the groups
are heterogeneous, the sample size relatively small and thus
interpretation limited.
The MHC isoform content of VL muscle of McArdle patients
and healthy controls were not different (MHC I: 33 6 19% vs. 41
6 9%; MHC IIa: 52 6 9% vs. 43 6 7%; MHC IIx: 15 6 18% vs.
16 6 9%) and was also the case for the BB muscle (MHC I: 336
14% vs. 29 6 11%; MHC IIa: 46 6 17% vs. 39 6 5%; MHC IIx:
21 6 13% vs. 32 6 14%) (Fig. 2). The relative fibre type
distributions obtained in this study are well in range with
published data on sedentary and recreationally active individuals.
For young (i.e. 20 to 30 years of age), inactive to recreationally
active individuals, the range in fibre type distribution in the VL is
approximately between 35 and 60% MHC I and 35 to 50% MHC
IIa. The amount of MHC IIx expressed in this muscle is not
particularly high, and can constitute approximately 25% of the
total MHC isoform composition (Klitgaard et al., 1990b; Kohn
et al., 2011; Monemi et al., 1999). Previous research has found a
weak, yet significant positive correlation between the percentage
type I muscle fibres and age (Gouzi et al., 2013). Unfortunately,
with the large range in standard deviation and overlap between
the 19 studies evaluated in the study by Gouzi et al. (Gouzi et al.,
2013), the average type I profile of the elderly ranged from 45 to
55%. It therefore suggests that age has a less important role in
determining fibre type. In the present study, there was no
relationship found between any of the MHC isoforms from the
two muscle groups and age.
It is well known that endurance athletes have a predominance
in MHC I and IIa isoforms and very little to no MHC IIx in their
VL, whereas resistance athletes may present with values similar
to inactive individuals (D’Antona et al., 2006; Kohn et al.,
2007b). Thus, physical activity levels seem to play a greater role
in determining the fibre type profile of a muscle. The MHC
isoform content of the BB from the controls and McArdle patients
were similar in range and agreed with data from Klitgaard et al.
(Klitgaard et al., 1990a) (included in Fig. 2), Monemi et al.
(Monemi et al., 1999) and Elder et al. (Elder et al., 1982). It has to
be emphasised though, that gender, age and trained status seems
to play a greater role in determining the size of the muscle fibre.
The McArdle patients of this study were encouraged by their
respective physicians to refrain from physical activity except for
those necessary for daily living. The patients were therefore
untrained and sedentary (Mate´-Mun˜oz et al., 2007).
Interestingly, isoform profiles for the McArdle patients were
similar for both muscles analysed, with the MHC I and IIa being
almost double that of MHC IIx. In contrast, the BB of controls
tended to have an equal distribution between the three isoforms,
whereas the VL predominantly expressed MHC I and IIa.
Fig. 1. Separation of the myosin heavy chain (MHC) isoforms into
three distinct bands using SDS-PAGE of a control and two McArdle
patients. In each well, a total of 1 mg protein and 2.5 mg protein were loaded
in the top and bottom gels, respectively.
Fig. 2. Myosin heavy chain isoform distribution in (A) Biceps brachii
and (B) Vastus lateralis from healthy participants (closed circles) and
patients diagnosed with McArdle disease (open circles). Values from the
literature (bars) are included for both muscle groups as reference points
(Klitgaard et al., 1990b). Where appropriate, data are presented as mean 6
SD.
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Unfortunately, the biopsy samples from this study could not be
used to determine cross-sectional area of individual muscle fibres
due to the long-term storage thereof. This would have been useful
to help account for the higher EMG activity at the same workload
observed previously (Rae et al., 2010). However, it seems that
fibre diameter of only type I fibres are affected by McArdle
disease, leaving the type II fibres unchanged (Felice et al., 1996).
In contrast, patients with Duchene’s muscular dystrophy have a
predominance of type I and IIA fibres, with very few to no type
IIX fibres (Fink et al., 1990). Thus, it could be argued that,
because fibre type in McArdle patients is not affected, and neither
is the type II fibre diameters, as proposed by previous research,
the contractility of individual fibres may be affected. It is well
known that contractility is affected by fibre diameter and the
latter affected by exercise type (Bottinelli, 2001). For example,
resistance training increases muscle fibre diameters, but
normalised force stays the same in single fibres (Shoepe et al.,
2003). Endurance exercise, on the other hand, tends to decrease
fibre size, but normalised force increases after training (Trappe
et al., 2006). Other factors such as myofibrillar concentration (i.e.
myosin and actin), myosin light chains and Ca2+ sensitivity could
affect the performance of single fibres (Bottinelli, 2001;
Ottenheijm et al., 2011).
Limitations of the present study are: (i) small sample size for
the control BB muscle (n 5 3) and overall power of the statistical
analyses, (ii) unknown biopsy location and depth for certain
individuals, (iii) no histology available when analyses were
performed.
With regards to the small sample size, this study was unable to
obtain more biopsies from healthy individuals from the BB. As
this muscle is considerably smaller than the VL, the norm today is
to perform most biopsies from the latter. Therefore, a limited
number of studies exist in the current literature concerning
biopsies from the BB. For both muscle groups, the sample sizes
were low, and therefore affected the power of the statistical
analyses. Using only the MHC I of the VL (percentage 6 SD, n),
the overall power was calculated as 0.195 with an alpha of 0.05.
By using the same data but increasing the samples size to 33 per
group, the power only increased to 0.213. To obtain a significant
power (0.90), we calculated the number of participants in each
group and amounted to 79 subjects per group, which is an
unrealistic number in terms of data collection.
It is well known that the location and depth of the biopsy can
significantly influence the fibre type composition (Elder et al.,
1982; Kohn and Myburgh, 2007). Unfortunately, it is not clear
where the exact location of the biopsy sites were for the McArdle
patients. As most neurologists prefer the open biopsy technique, it
was assumed that the McArdle biopsies (VL and BB) and the BB
from the three controls were performed using the open biopsy
technique, which will mostly sample superficially. On the other
hand, the control VL biopsies were all obtained using the
percutaneous suction assisted technique at a standard depth of
2 cm. Nevertheless, the data from the present study for VL and
BB falls well within those obtained for the control participants, as
well as the current literature. If the proposed hypothesis were
true, a predominance in type I fibres would have been observed in
McArdle patients, irrespective of biopsy location.
In conclusion, the data from this study suggested that fibre type
distribution does not explain the higher surface EMG in McArdle
patients. The skeletal muscle groups (VL and BB) of the male and
female McArdle patients used in this study expresses a normal
range for each MHC isoform compared to healthy individuals.
These data support the suggestion that altered single muscle fibre
contractility, fibre diameters or other proteins forming part of the
contractile apparatus may partly account for the abnormal muscle
recruitment previously observed in McArdle patients (Rae et al.,
2010).
MATERIALS AND METHODS
Participants
Muscle samples from McArdle patients analysed in this study were
collected as part of a larger study, the details of which have been
published previously (Mate´-Mun˜oz et al., 2007). Written informed
consent was obtained from these patients that a part of the tissue could be
used for research purposes and was approved by the Ethics Committee
(Hospital 12 de Octubre, Madrid, Spain). Muscle biopsies were collected
from 17 patients (8 male, 9 female, age: 41 6 18 years) diagnosed with
McArdle disease over a 13-year period. VL biopsies (3 male, 5 female,
mean age: 486 19 years) or BB biopsies (5 male, 4 female, mean age: 35
6 16 years) were rapidly frozen in liquid nitrogen and stored at 280 C˚.
VL biopsies from 10 recreationally active males (mean age: 25 6 2) and
BB biopsies from two males and one female (age: 35 6 10), forming part
of previous studies, served as healthy control. Descriptive statistics of the
participants are listed in Table 1.
McArdle disease was diagnosed by genetic analysis and, in most cases,
also confirmed by undetectable myophosphorylase activity and negative
myophosphorylase histochemical staining in the muscle biopsies, as
previously published (Lucia et al., 2008; Lucia et al., 2012).
Relative muscle fibre type quantification
The myosin heavy chain isoform content of the muscle samples was
separated using SDS-PAGE, as described in detail (Kohn et al., 2011).
Electrophoresis was carried out at 70 V for 4 hours at 4 C˚, followed by
275 V for 20 hours. Gels were silver stained, scanned and the
densitometric profile of the bands determined (Fig. 1) (Un-Scan-It, Silk
Scientific Inc, Utah). Each sample was twice electrophoresed, the first at
a total concentration of 1 mg and the second at 2.5 mg to ensure adequate
detection of the three isoforms and any additional bands that could
correspond to the embryonic, neonatal or the MHC IIb isoform.
Table 1. Descriptive data of healthy control participants and McArdle patients
N Age (years) Gender Weight (kg) Height (cm) BMI (kg/m2)
Biceps brachii
Healthy control 3 35 6 10 26M; 16F 66 6 14 165 6 6 24 6 4
(27–47) (50–76) (159–170) (20–27)
McArdle patients 9 35 6 16 56M; 46F 66 6 12 170 6 3 23 6 4
(17–61) (52–75) (167–173) (19–26)
Vastus lateralis
Healthy control 10 25 6 2 106M 65 6 13 175 6 5 21 6 5
(19–27) (49–95) (167–181) (17–32)
McArdle patients 8 48 6 19 36M; 56F 68 6 17 166 6 10 24 6 4
(17–76) (53–92) (160–180) (20–28)
Data are presented as mean 6 SD. Values in parentheses are ranges. BMI, body mass index; F, female; M, male.
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Statistical analyses
Data are presented as mean 6 standard deviation and subjected to a non-
parametric ANOVA (Kruskal-Wallis test) and a Dunn’s multiple
comparisons post-hoc test (GraphPad Prism). Relationships were
determined using the non-parametric Spearman r correlation
coefficient. Significance was set at P , 0.05.
List of abbreviations
BB, Biceps brachii; EMG, Electromyographic; MHC, Myosin heavy
chain; VL, Vastus lateralis.
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